Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Food prescription program aims to lower blood sugar in food-insecure diabetics

NCT ID NCT04725630

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving adults with type 2 diabetes and food insecurity a small weekly incentive ($10.50 per household member) to buy healthy foods could improve their blood sugar control. 597 participants were randomly assigned to receive either the food incentive plus a healthy food prescription pamphlet, or just the pamphlet alone. The main goal was to see if the incentive group had lower blood sugar levels (measured by hemoglobin A1C) after 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
healthy food incentive ($10.50/week/household member for 12 months)
What this could lead to
If it works, this could show that helping people afford healthy food improves blood sugar control and reduces diabetes complications.
What could go wrong
This is a completed study, but the intervention is small ($10.50/week) and may not be enough to make a lasting difference. Results may not apply to everyone with diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

597 people

The number who actually took part.

Started

May 2021

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (18-85 years) with type 2 diabetes (or diabetes of unknown etiology) * Persistent hyperglycemia (i.e. hemoglobin A1C 6.5-12%) * Are currently experiencing food insecurity and/or report that it is difficult/very difficult to make ends meet * Can communicate in English or have someone to translate Exclusion Criteria: * A1c \<6.5% or \> 12% given the recommendation for anti-hyperglycemic treatment escalation for those with A1c\>12% * Reside in a facility that provides meals (e.g., shelter, long-term care, prison) * Exhibit signs/symptoms of metabolic decompensation (weight loss, polyuria, polydipsia) * Diagnosis of eating disorder(s) (e.g., anorexia nervosa, bulimia) * Have experienced diabetic ketoacidosis or a hyperglycemic hyperosmolar emergency in the past year * Experienced a hypoglycemic event in the past 3 months * Are trying to conceive, pregnant and/or breastfeeding * Are currently participating in other clinical trials * A household member is currently or has previously participated in this trial * Unwilling/unable to shop in study-affiliated supermarkets for the next 12 months * Plan to leave for Canada for more than 2 weeks in the next 12 months * Unable to complete data collection at follow-up (e.g., due to moving)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes complications are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Diabetes Complications type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Primary Care Clinics

    Various Cities, Alberta, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.